Khiron Life Sciences Corp.
KHRNF · OTC
9/30/2022 | 6/30/2022 | 3/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $2 | $6 | $5 | $9 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $4 | $4 | $4 | $3 |
| Inventory | $10 | $9 | $10 | $9 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $18 | $22 | $22 | $24 |
| Property Plant & Equip (Net) | $13 | $14 | $15 | $14 |
| Goodwill | $6 | $4 | $4 | $4 |
| Intangibles | $1 | $1 | $1 | $1 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $20 | $19 | $20 | $19 |
| Other Assets | $0 | -$0 | -$0 | $0 |
| Total Assets | $38 | $40 | $42 | $42 |
| Liabilities | – | – | – | – |
| Payables | $7 | $7 | $6 | $4 |
| Short-Term Debt | $0 | $0 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1 | $1 | $1 | $3 |
| Total Curr. Liab. | $10 | $8 | $11 | $8 |
| LT Debt | $1 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $1 | $2 | $3 | $1 |
| Total NC Liab. | $2 | $2 | $1 | $1 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $0 | $0 | $0 |
| Total Liabilities | $11 | $10 | $12 | $9 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $152 | $150 | $147 | $146 |
| Retained Earnings | -$128 | -$124 | -$122 | -$117 |
| AOCI | $3 | $4 | $5 | $4 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $27 | $30 | $30 | $33 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $38 | $40 | $42 | $42 |
| Net Debt | -$0 | -$5 | -$4 | -$8 |